Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

Zai Lab Limited ADR (NASDAQ: ZLAB) closed the day trading at $34.08 down -11.98% from the previous closing price of $38.72. In other words, the price has decreased by -$11.98 from its previous closing price. On the day, 1.67 million shares were traded. ZLAB stock price reached its highest trading level at $35.075 during the session, while it also had its lowest trading level at $33.19.

Ratios:

For a better understanding of ZLAB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.09 and its Current Ratio is at 3.26. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.02.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $55.

On March 03, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $29 to $36.10. On December 14, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $47.50.Morgan Stanley initiated its Overweight rating on December 14, 2023, with a $47.50 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 02 ’25 when Du Ying sold 7,072 shares for $35.23 per share. The transaction valued at 249,147 led to the insider holds 536,962 shares of the business.

Du Ying bought 7,072 shares of ZLAB for $249,144 on Jul 02 ’25. On Jun 30 ’25, another insider, Du Ying, who serves as the Chairperson & CEO of the company, sold 6,918 shares for $35.52 each. As a result, the insider received 245,727 and left with 526,034 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 4276086016 and an Enterprise Value of 41436315648. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.02 while its Price-to-Book (P/B) ratio in mrq is 4.56. Its current Enterprise Value per Revenue stands at 99.053 whereas that against EBITDA is -161.976.

Stock Price History:

The Beta on a monthly basis for ZLAB is 1.04, which has changed by 1.0959411 over the last 52 weeks, in comparison to a change of 0.18634176 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $44.34, while it has fallen to a 52-week low of $16.01. The 50-Day Moving Average of the stock is -6.12%, while the 200-Day Moving Average is calculated to be 7.99%.

Shares Statistics:

Over the past 3-months, ZLAB traded about 890.32K shares per day on average, while over the past 10 days, ZLAB traded about 844280 shares per day. A total of 110.59M shares are outstanding, with a floating share count of 109.14M. Insiders hold about 1.31% of the company’s shares, while institutions hold 47.51% stake in the company. Shares short for ZLAB as of 1752537600 were 3982298 with a Short Ratio of 4.47, compared to 1749772800 on 4388732. Therefore, it implies a Short% of Shares Outstanding of 3982298 and a Short% of Float of 4.099999700000001.

Earnings Estimates

The company has 1.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between -$1.66 and -$1.66 for the fiscal current year, implying an average EPS of -$1.66. EPS for the following year is $0.19, with 8.0 analysts recommending between $0.8 and -$0.97.

Revenue Estimates

7 analysts predict $151.37M in revenue for the current quarter. It ranges from a high estimate of $157.9M to a low estimate of $141.62M. As of the current estimate, Zai Lab Limited ADR’s year-ago sales were $102.27MFor the next quarter, 7 analysts are estimating revenue of $185.21M. There is a high estimate of $201.96M for the next quarter, whereas the lowest estimate is $176.8M.

A total of 16 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $591.32M, while the lowest revenue estimate was $547.7M, resulting in an average revenue estimate of $565.46M. In the same quarter a year ago, actual revenue was $398.99MBased on 15 analysts’ estimates, the company’s revenue will be $856.22M in the next fiscal year. The high estimate is $1.04B and the low estimate is $760.8M.